Cross Country Healthcare, Inc.
CCRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $250,052 | $274,072 | $293,408 | $309,940 |
| % Growth | -8.8% | -6.6% | -5.3% | – |
| Cost of Goods Sold | $199,125 | $218,068 | $234,750 | $247,948 |
| Gross Profit | $50,927 | $56,004 | $58,658 | $61,992 |
| % Margin | 20.4% | 20.4% | 20% | 20% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $46,842 |
| SG&A Expenses | $0 | $50,050 | $52,486 | $55,342 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $8,500 |
| Other Operating Expenses | $56,900 | $11,813 | $7,149 | $10,083 |
| Operating Expenses | $56,900 | $61,863 | $59,635 | $65,425 |
| Operating Income | -$5,973 | -$5,859 | -$977 | -$3,433 |
| % Margin | -2.4% | -2.1% | -0.3% | -1.1% |
| Other Income/Exp. Net | $336 | $130 | $78 | -$481 |
| Pre-Tax Income | -$5,637 | -$5,729 | -$899 | -$3,914 |
| Tax Expense | -$863 | $930 | -$409 | -$161 |
| Net Income | -$4,774 | -$6,659 | -$490 | -$3,753 |
| % Margin | -1.9% | -2.4% | -0.2% | -1.2% |
| EPS | -0.15 | -0.2 | -0.02 | -0.12 |
| % Growth | 25% | -900% | 83.3% | – |
| EPS Diluted | -0.15 | -0.2 | -0.02 | -0.12 |
| Weighted Avg Shares Out | 32,524 | 32,492 | 32,282 | 32,338 |
| Weighted Avg Shares Out Dil | 32,524 | 32,492 | 32,282 | 32,338 |
| Supplemental Information | – | – | – | – |
| Interest Income | $864 | $702 | $681 | $535 |
| Interest Expense | $556 | $549 | $543 | $608 |
| Depreciation & Amortization | $4,088 | $4,101 | $4,772 | $3,641 |
| EBITDA | -$993 | -$1,079 | $4,416 | $3,982 |
| % Margin | -0.4% | -0.4% | 1.5% | 1.3% |